Gate Neurosciences
PrivateLast Round
M&A
May 27, 2025
Total Funding Raised
$58.9M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Gate Neurosciences is a biotechnology company that develops precision medicines to treat central nervous system disorders by enhancing synaptic function and neuroplasticity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials, Mental Health
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gate Neurosciences Comparables
Compare Gate Neurosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Otsuka Holdings | 81% | |
| Delix Therapeutics | 81% | |
| Spinogenix, Inc. | 78% |
Gate Neurosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | May 27, 2025 | ||||
| Convertible Debt | Dec 31, 2024 | ||||
| Convertible Debt | Sep 30, 2022 | ||||
| Convertible Debt | Nov 24, 2021 |
Key People
Founding team and executive leadership
Gate Neurosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioCrossroads | Convertible Debt, Seed |
| Luson BioVentures | Convertible Debt, M&A |
| Innoviva | Convertible Debt, M&A |
| Catalio Capital Management | M&A |
| M Capital | M&A |
| PagodaTree Partners | M&A |
| Tenmile | M&A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2026
Open roles increased by 2, representing 200% of headcount.
- May 27, 2025
$62M round led by Innoviva and Catalio Capital Management.
Gate Neurosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Gate Neurosciences's valuation, stock price, and market status.
Is Gate Neurosciences a public or private company?
Gate Neurosciences is a private company.
What is the current stock price of Gate Neurosciences?
Gate Neurosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Gate Neurosciences worth (valuation)?
Valuation information for Gate Neurosciences is not publicly available.
Can I buy Gate Neurosciences stock?
Gate Neurosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Gate Neurosciences's last funding round?
Gate Neurosciences's most recent funding round was VC Round on October 5, 2022.
Who are the main investors in Gate Neurosciences?
Key investors in Gate Neurosciences include BioCrossroads, Luson BioVentures, Innoviva.
Will Gate Neurosciences IPO soon?
No public IPO plans have been announced for Gate Neurosciences.
How can I track Gate Neurosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Gate Neurosciences's secondary market activity and sign up for updates.